Prognostic impact of gene copy number instability and tumor mutation burden in patients with resectable gastric cancer
- PMID: 32141230
- PMCID: PMC7163787
- DOI: 10.1002/cac2.12007
Prognostic impact of gene copy number instability and tumor mutation burden in patients with resectable gastric cancer
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
A novel assessing system for predicting the prognosis of gastric cancer.Epigenomics. 2019 Aug;11(11):1251-1266. doi: 10.2217/epi-2019-0151. Epub 2019 Jul 31. Epigenomics. 2019. PMID: 31364879
-
Impressive response to immunotherapy in a metastatic gastric cancer patient: could somatic copy number alterations help patient selection?J Immunother Cancer. 2017 Nov 21;5(1):84. doi: 10.1186/s40425-017-0291-9. J Immunother Cancer. 2017. PMID: 29157298 Free PMC article.
-
Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives.World J Gastroenterol. 2019 Oct 14;25(38):5773-5788. doi: 10.3748/wjg.v25.i38.5773. World J Gastroenterol. 2019. PMID: 31636471 Free PMC article. Review.
-
Gene copy number gain of EGFR is a poor prognostic biomarker in gastric cancer: evaluation of 855 patients with bright-field dual in situ hybridization (DISH) method.Gastric Cancer. 2016 Jan;19(1):63-73. doi: 10.1007/s10120-014-0449-9. Epub 2014 Dec 9. Gastric Cancer. 2016. PMID: 25487305
-
The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.Crit Rev Oncol Hematol. 2018 Jul;127:15-28. doi: 10.1016/j.critrevonc.2018.05.004. Epub 2018 May 16. Crit Rev Oncol Hematol. 2018. PMID: 29891108 Review.
Cited by
-
Comprehensive Multiomics Analyses Establish the Optimal Prognostic Model for Resectable Gastric Cancer : Prognosis Prediction for Resectable GC.Ann Surg Oncol. 2024 Mar;31(3):2078-2089. doi: 10.1245/s10434-023-14249-x. Epub 2023 Nov 23. Ann Surg Oncol. 2024. PMID: 37996637
-
Prognostic value of tumor mutation burden in patients with advanced gastric cancer receiving first-line chemotherapy.Front Oncol. 2023 Jan 4;12:1007146. doi: 10.3389/fonc.2022.1007146. eCollection 2022. Front Oncol. 2023. PMID: 36686739 Free PMC article.
-
The Most Comprehensive Study at Single-Cell Resolution: A Giant Step toward Understanding Gastric Cancer.Glob Med Genet. 2022 Dec 8;9(4):265-267. doi: 10.1055/s-0042-1758763. eCollection 2022 Dec. Glob Med Genet. 2022. PMID: 36530529 Free PMC article. No abstract available.
-
Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple-negative breast cancer.Cancer Med. 2023 Mar;12(5):5846-5858. doi: 10.1002/cam4.5372. Epub 2022 Oct 21. Cancer Med. 2023. PMID: 36271505 Free PMC article.
-
Comprehensive Genomic and Epigenomic Analyses on Transcriptomic Regulation in Stomach Adenocarcinoma.Front Genet. 2022 Feb 11;12:778095. doi: 10.3389/fgene.2021.778095. eCollection 2021. Front Genet. 2022. PMID: 35222516 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. - PubMed
-
- Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32. - PubMed
-
- Wang FH, Shen L, Li J, Zhou ZW, Liang H, Zhang XT, et al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer. (2523–3548 (Electronic)).
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
